Current Ratio in % of Elicio Therapeutics, Inc. from Q3 2021 to Q3 2025

Taxonomy & unit: ratio: %
Description: The current ratio is a liquidity ratio that measures a company's ability to cover its short-term obligations with its current assets.
Summary: Elicio Therapeutics, Inc. quarterly Current Ratio history and change rate from Q3 2021 to Q3 2025.
Elicio Therapeutics, Inc. Current Ratio for the quarter ending 30 Sep 2025 was 218 %, a 3.7% increase year-over-year.

Current Ratio, Quarterly (%)

Current Ratio, YoY Quarterly Change (%)

Elicio Therapeutics, Inc. Quarterly Current Ratio (%)

Period	Value	YoY Chg	Change %	Date
Q3 2025	218	+7.76	+3.7%	30 Sep 2025
Q2 2025	227	+62.4	+38%	30 Jun 2025
Q1 2025	200	-20.6	-9.34%	31 Mar 2025
Q4 2024	212	-122	-36.6%	31 Dec 2024
Q3 2024	210	-139	-39.8%	30 Sep 2024
Q2 2024	164	-380	-69.8%	30 Jun 2024
Q1 2024	220	-479	-68.5%	31 Mar 2024
Q4 2023	334	-297	-47%	31 Dec 2023
Q3 2023	348	-422	-54.8%	30 Sep 2023
Q2 2023	544	-169	-23.7%	30 Jun 2023
Q1 2023	700	+48.5	+7.45%	31 Mar 2023
Q4 2022	631	-41.8	-6.21%	31 Dec 2022
Q3 2022	771	+525	+214%	30 Sep 2022
Q2 2022	713			30 Jun 2022
Q1 2022	651			31 Mar 2022
Q4 2021	673			31 Dec 2021
Q3 2021	246			30 Sep 2021

* An asterisk sign (*) next to the value indicates that the value is likely invalid.